Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-006615
Filing Date
2025-06-25
Accepted
2025-06-25 10:36:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27706
2 filename2.txt TEXT-EXTRACT 1179
  Complete submission text file 0000000000-25-006615.txt   40096
Mailing Address 1000 N. WEST STREET, SUITE 1200 WILMINGTON DE 19801
Business Address 1000 N. WEST STREET, SUITE 1200 WILMINGTON DE 19801 (302) 295-3800
Inhibikase Therapeutics, Inc. (Filed for) CIK: 0001750149 (see all company filings)

EIN.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-288213
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)